Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02103699 · ClinicalTrials.gov registry record
A Study to Examine Patient Characteristics, Health Care Management and Health Outcomes of Hepatitis C Virus (HCV) Patients Treated With Simeprevir
A clinical trial, sponsored by Janssen Scientific Affairs.
- Completed
- Registry status
- 315
- Enrollment target
NCT02103699 is a clinical trial that has completed, run by Janssen Scientific Affairs. The registered enrollment target is 315 participants.
The verdict
NCT02103699 has completed, sponsored by Janssen Scientific Affairs.
- COMPLETED
- Registry status
- 315 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of a simeprevir-containing hepatitis C virus (HCV) treatment regimen as measured by sustained virologic response (SVR).
Interventions
- DRUG No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 315 participants |
| Start Date | 2014-02 |
| Est. Completion | 2016-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02103699
The ClinicalTrials.gov registry entry for NCT02103699 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 315 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Janssen Scientific Affairs, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT02103699 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02103699 about?
NCT02103699 is a clinical study titled "A Study to Examine Patient Characteristics, Health Care Management and Health Outcomes of Hepatitis C Virus (HCV) Patients Treated With Simeprevir". The purpose of this study is to evaluate the effectiveness of a simeprevir-containing hepatitis C virus (HCV) treatment regimen as measured by sustained virologic response (SVR).
What is the current status of trial NCT02103699?
This trial is currently completed. The enrollment target is 315 participants. The study started on 2014-02. Estimated completion is 2016-01.
What interventions are being tested in trial NCT02103699?
The interventions under investigation include: No intervention (DRUG).
Who is sponsoring clinical trial NCT02103699?
This trial is sponsored by Janssen Scientific Affairs, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.